Successful Up-front Combination Therapy in a Patient With Idiopathic Pulmonary Hypertension and Patent Foramen Ovale: An Alternative to Epoprostenol Therapy?

Journal of Heart and Lung Transplantation

Volumn 28, Issue 6, 2009, Pages 651-653

  Pitsiou, Georgia G ^a   Chavouzis, Nikolaos ^a   Nakou, Chrysanthi ^a   Boutou, Afroditi K ^a   Argyropoulou, Paraskevi ^a   Stanopoulos, Ioannis ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ILOPROST; PROSTACYCLIN; SILDENAFIL; SITAXSENTAN; WARFARIN;

ADULT; ARTICLE; CASE REPORT; CLINICAL ASSESSMENT; DISEASE SEVERITY; ELECTROCARDIOGRAPHY; FEMALE; FUNCTIONAL ASSESSMENT; HEART RIGHT LEFT SHUNT; HEMODYNAMICS; HUMAN; HYPOXEMIA; IDIOPATHIC DISEASE; INTENSIVE CARE UNIT; LUNG DIFFUSION CAPACITY; LUNG FUNCTION TEST; OXYGENATION; PATENT FORAMEN OVALE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; ANTIHYPERTENSIVE AGENTS; DRUG THERAPY, COMBINATION; EPOPROSTENOL; FEMALE; FORAMEN OVALE, PATENT; HUMANS; HYPERTENSION, PULMONARY; ILOPROST; ISOXAZOLES; PIPERAZINES; PURINES; RECEPTOR, ENDOTHELIN A; SULFONES; THIOPHENES; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 65749118528     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2009.03.009     Document Type: Article

References (9)

1. Humbert M., Sibton O., and Simonneau G. Treatment for pulmonary arterial hypertension. N Engl J Med 351 (2004) 1425-1436
2. Badesch D.B., Abman S.H., Ahearn G.S., et al. Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 126 suppl 1 (2004) 35S-62S
3. Conte J.V., Gaine S.P., Orens J.B., et al. The influence of continuous intravenous prostacyclin on the timing and outcome of transplantation for primary pulmonary hypertension. J Heart Lung Transplant 17 (1998) 679-685
4. Laine J.F., Slama M., Petitpretz P., et al. Danger of vasodilator therapy for pulmonary hypertension in patent foramen ovale. Chest 89 (1986) 894-895
5. Michelakis E., Tymchak W., Lien D., et al. Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension: comparison with inhaled nitric oxide. Circulation 20 (2002) 2398-2403
6. Ghofrani H.A., Wiedemann R., Rose F., et al. Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension. Ann Intern Med 136 (2002) 515-522
7. Keogh A.M., Jabbour A., Weintraub R., et al. Safety and efficacy of transition from subcutaneous treprostinil to oral sildenafil in patients with pulmonary arterial hypertension. J Heart Lung Transplant 26 (2007) 1079-1083
8. Karakaya O., Ozdemir N., Kaymaz C., et al. Dramatic decrease in the pulmonary artery systolic pressure and disappearance of the interatrial shunt with sildenafil treatment in a patient with primary pulmonary hypertension with atrial septal aneurysm and a severe right to left shunt through the patent foramen ovale. Int J Cardiol 110 (2006) 97-99
9. Barst R.J., Langleben D., Frost A., et al. Sitaxsentan therapy for pulmonary arterial hypertension. Am J Respir Crit Care Med 169 (2004) 441-447